Exchange Traded Concepts, LLC Exact Sciences Corp Transaction History

Exchange Traded Concepts, LLC

$10.4 Billion
Q3 2025

A detailed history of Exchange Traded Concepts, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 14,976 shares of EXAS stock, worth $949,628. This represents 0.01% of its overall portfolio holdings.

Number of Shares

14,976

Previous 12,309 21.67%

Holding current value

$949,628

Previous $654,000 25.23%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 14, 2025	BUY	$40.91 - $56.0 $109,106 - $149,352	2,667 Added 21.67%	14,976 $819,000
Q2 2025 Jul 10, 2025	SELL	$40.31 - $58.08 $126,291 - $181,964	-3,133 Reduced 20.29%	12,309 $654,000
Q1 2025 Apr 17, 2025	BUY	$43.04 - $58.51 $162,389 - $220,758	3,773 Added 32.33%	15,442 $668,000
Q4 2024 Jan 21, 2025	SELL	$49.33 - $71.97 $41,585 - $60,670	-843 Reduced 6.74%	11,669 $655,000
Q3 2024 Oct 10, 2024	SELL	$42.43 - $70.83 $247,324 - $412,868	-5,829 Reduced 31.78%	12,512 $851,000
Q2 2024 Aug 13, 2024	BUY	$41.33 - $74.26 $151,846 - $272,831	3,674 Added 25.05%	18,341 $774,000
Q1 2024 Apr 15, 2024	BUY	$56.27 - $73.77 $122,443 - $160,523	2,176 Added 17.42%	14,667 $1.01 Million
Q4 2023 Jan 05, 2024	SELL	$59.06 - $75.72 $194,838 - $249,800	-3,299 Reduced 20.89%	12,491 $924,000
Q3 2023 Oct 18, 2023	BUY	$65.94 - $99.04 $88,095 - $132,317	1,336 Added 9.24%	15,790 $1.08 Million
Q2 2023 Jul 20, 2023	SELL	$62.68 - $95.05 $264,384 - $400,920	-4,218 Reduced 22.59%	14,454 $1.36 Million
Q1 2023 Apr 12, 2023	SELL	$47.19 - $70.77 $454,911 - $682,222	-9,640 Reduced 34.05%	18,672 $1.27 Million
Q4 2022 Jan 17, 2023	SELL	$30.35 - $53.15 $203,314 - $356,051	-6,699 Reduced 19.13%	28,312 $1.4 Million
Q3 2022 Oct 07, 2022	BUY	$31.97 - $49.37 $228,649 - $353,094	7,152 Added 25.67%	35,011 $1.14 Million
Q2 2022 Jul 20, 2022	SELL	$35.61 - $76.23 $38,601 - $82,633	-1,084 Reduced 3.75%	27,859 $1.1 Million
Q1 2022 Apr 26, 2022	SELL	$57.56 - $82.54 $311,917 - $447,284	-5,419 Reduced 15.77%	28,943 $2.02 Million
Q4 2021 Jan 13, 2022	BUY	$72.5 - $100.68 $273,470 - $379,764	3,772 Added 12.33%	34,362 $2.67 Million
Q3 2021 Oct 18, 2021	BUY	$90.24 - $124.05 $150,430 - $206,791	1,667 Added 5.76%	30,590 $2.92 Million
Q2 2021 Jul 30, 2021	BUY	$93.66 - $139.27 $573,854 - $853,307	6,127 Added 26.88%	28,923 $3.6 Million
Q1 2021 Apr 20, 2021	BUY	$116.57 - $155.01 $1.19 Million - $1.59 Million	10,230 Added 81.41%	22,796 $3 Million
Q4 2020 Jan 19, 2021	BUY	$99.61 - $142.12 $424,139 - $605,146	4,258 Added 51.25%	12,566 $1.67 Million
Q3 2020 Oct 30, 2020	BUY	$72.92 - $102.01 $307,503 - $430,176	4,217 Added 103.08%	8,308 $847,000
Q2 2020 Jul 15, 2020	BUY	$55.75 - $92.75 $99,792 - $166,022	1,790 Added 77.79%	4,091 $356,000
Q1 2020 Apr 14, 2020	BUY	$37.9 - $104.44 $46,958 - $129,401	1,239 Added 116.67%	2,301 $133,000
Q4 2019 Jan 22, 2020	BUY	$77.66 - $99.74 $82,474 - $105,923	1,062 New	1,062 $98,000

Others Institutions Holding EXAS

# of Institutions

650

Shares Held

156M

Call Options Held

1.43M

Put Options Held

2.3M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $11.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Account

Exchange Traded Concepts, LLC Exact Sciences Corp Transaction History